Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Mabs|September 24, 2016
Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application scheduleMichael Dobosz, Ute Haupt, Werner Scheuer
Histochemistry and Cell Biology|October 6, 2016
Deep tissue imaging: a review from a preclinical cancer research perspectiveAnnette Feuchtinger, Axel Walch, Michael Dobosz
Neoplasia (New York, N.Y.)|February 25, 2014
Multispectral fluorescence ultramicroscopy: three-dimensional visualization and automatic quantification of tumor morphology, drug penetration, and antiangiogenic treatment responseMichael Dobosz, Vasilis Ntziachristos, Werner Scheuer, et al.
Journal of Biomedical Optics|January 30, 2014
Noninvasive measurement of pharmacokinetics by near-infrared fluorescence imaging in the eye of miceMichael Dobosz, Steffen Strobel, Kay-Gunnar Stubenrauch, et al.
Science Translational Medicine|May 18, 2012
Drug-based optical agents: infiltrating clinics at lower riskWerner Scheuer, Gooitzen M van Dam, Michael Dobosz, et al.
European Radiology|November 11, 2016
Quantification of antiangiogenic treatment effects on tissue heterogeneity in glioma tumour xenograft model using a combination of DCE-MRI and 3D-ultramicroscopyMarco Dominietto, Michael Dobosz, Sandra Bürgi, et al.
ACS Nano|April 22, 2016
Three-Dimensional Optical Mapping of Nanoparticle Distribution in Intact TissuesShrey Sindhwani, Abdullah Muhammad Syed, Stefan Wilhelm, et al.
Investigative Radiology|March 7, 2014
Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenograftsThomas Pöschinger, Anja Renner, Fabian Eisa, et al.
JCO Precision Oncology|August 1, 2025
Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma SubtypesDenise M Connolly, Gabriel Revon-Rivière, Rose Chami, et al.
Gut|April 5, 2024
Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel diseaseRuben Y Gabriëls, Anne M van der Waaij, Matthijs D Linssen, et al.
Pageof 2